Cargando…

Naturally-occurring hepatitis C virus protease variants: implications for resistance to new antivirals

Detalles Bibliográficos
Autores principales:	López-Labrador, F.X., Moya, A., González-Candelas, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2006
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128535/ http://dx.doi.org/10.1016/S1386-6532(06)80832-2

Ejemplares similares

Recombination in Hepatitis C Virus
por: González-Candelas, Fernando, et al.
Publicado: (2011)

Computational models of liver fibrosis progression for hepatitis C virus chronic infection
por: Lara, James, et al.
Publicado: (2014)

Virion Secretion of Hepatitis B Virus Naturally Occurring Core Antigen Variants
por: Shih, Chiaho, et al.
Publicado: (2020)

Evolution of naturally occurring 5'non-coding region variants of Hepatitis C virus in human populations of the South American region
por: Moratorio, Gonzalo, et al.
Publicado: (2007)

Hepatitis C Virus Induces Regulatory T Cells by Naturally Occurring Viral Variants to Suppress T Cell Responses
por: Cusick, Matthew F., et al.
Publicado: (2011)

Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection
por: Ayatollahi, Seyed Abdulmajid, et al.
Publicado: (2021)

Naturally Occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive HCV Genotype 6a-Infected Patients
por: Li, Zhanyi, et al.
Publicado: (2017)

Targeting naturally occurring epitope variants of hepatitis C virus with high-affinity T-cell receptors
por: Zhang, Huajun, et al.
Publicado: (2017)

Author's overview: identifying SARS-CoV-2 antiviral compounds
por: Diffley, John F.X.
Publicado: (2021)

Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression
por: Choi, Yu-Min, et al.
Publicado: (2018)

Naturally occurring hepatitis B virus surface antigen mutant variants in Malaysian blood donors and vaccinees
por: Hudu, S. A., et al.
Publicado: (2015)

Molecular models of NS3 protease variants of the Hepatitis C virus
por: da Silveira, Nelson JF, et al.
Publicado: (2005)

Analysis of Naturally Occurring Resistant Mutations to Hepatitis C Virus NS3 Protease Inhibitors: A Preliminary Study in South of Iran
por: Afrasiabi, Mozhgan, et al.
Publicado: (2015)

Naturally occurring drug resistance associated variants to hepatitis C virus direct-acting antiviral agents in treatment-naive HCV genotype 1b-infected patients in China
por: Li, Zhanyi, et al.
Publicado: (2017)

Molecular evolution in court: analysis of a large hepatitis C virus outbreak from an evolving source
por: González-Candelas, Fernando, et al.
Publicado: (2013)

A naturally occurring antiviral ribonucleotide encoded by the human genome
por: Gizzi, Anthony S., et al.
Publicado: (2018)

New developments in the management of hepatitis C virus infection: focus on boceprevir
por: Berenguer, Marina, et al.
Publicado: (2012)

Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients
por: Paolucci, Stefania, et al.
Publicado: (2012)

PIN12 - HOSPITALIZATIONS RELATED TO RESPIRATORY VIRAL INFECTIONS DURING THE 2017/18 SEASON IN THE VALENCIA REGION OF SPAIN
por: Mira-Iglesias, A., et al.
Publicado: (2018)

Hepatitis C Virus and Natural Compounds: a New Antiviral Approach?
por: Calland, Noémie, et al.
Publicado: (2012)

The antiviral activity of naturally occurring proteins and their peptide fragments after chemical modification
por: Oevermann, Anna, et al.
Publicado: (2003)

Evidence of Recombination in Intrapatient Populations of Hepatitis C Virus
por: Sentandreu, Vicente, et al.
Publicado: (2008)

The population genetics and evolutionary epidemiology of RNA viruses
por: Moya, Andrés, et al.
Publicado: (2004)

Two Cases of Hepatocellular Carcinoma Occurring Immediately after Direct-acting Antiviral Agents against Hepatitis C Virus
por: Nishijima, Norihiro, et al.
Publicado: (2018)

Protease inhibitors, inflammatory markers, and their association with outcome in dogs with naturally occurring acute pancreatitis
por: Kuzi, Sharon, et al.
Publicado: (2020)

Naturally Occurring Follicle-Stimulating Hormone Glycosylation Variants
por: Davis, John S, et al.
Publicado: (2014)

Naturally Occurring Hepatitis B Virus B-Cell and T-Cell Epitope Mutants in Hepatitis B Vaccinated Children
por: Lin, Yu-Min, et al.
Publicado: (2013)

Differential hepatitis C virus RNA target site selection and host factor activities of naturally occurring miR-122 3΄ variants
por: Yamane, Daisuke, et al.
Publicado: (2017)

Investigation of Naturally Occurring Single-Nucleotide Variants in Human TAAR1
por: Mühlhaus, Jessica, et al.
Publicado: (2017)

Functional and Pharmacological Analyses of the Role of Penicillium digitatum Proteases on Virulence
por: Ballester, Ana-Rosa, et al.
Publicado: (2019)

Naturally occurring genotype 2b/1a hepatitis C virus in the United States
por: Bhattacharya, Dipankar, et al.
Publicado: (2011)

Recombination in Hepatitis C Virus: Identification of Four Novel Naturally Occurring Inter-Subtype Recombinants
por: Shi, Weifeng, et al.
Publicado: (2012)

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir
por: Ng, Teresa I., et al.
Publicado: (2017)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease
por: Milligan, Jennifer C., et al.
Publicado: (2021)

Naturally occurring C-terminal splice variants of nuclear receptors
por: van der Vaart, Michiel, et al.
Publicado: (2009)

Identification and characterization of naturally occurring splice variants of SAMHD1
por: Welbourn, Sarah, et al.
Publicado: (2012)

Biochemical Properties of Naturally Occurring Human Bloom Helicase Variants
por: Cueny, Rachel R., et al.
Publicado: (2023)

Biochemical properties of naturally occurring human bloom helicase variants
por: Cueny, Rachel R., et al.
Publicado: (2023)

Antiviral strategies for hepatitis E virus
por: Debing, Yannick, et al.
Publicado: (2014)

The Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease Inhibitors
por: Nguyen, Linh Thuy, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qud8gc3k974e1p3l500m4k1qvg